The nonlinear association between red blood cell distribution width (RDW) and bortezomib-related peripheral neurotoxicity (PN): A retrospective cohort study

Liu, 2019, Incidence and mortality of multiple myeloma in China, 2006-2016: an analysis of the global burden of disease study 2016, J. Hematol. Oncol., 12, 136, 10.1186/s13045-019-0807-5 Cowan, 2022, Diagnosis and management of multiple myeloma: a review, JAMA, 327, 464, 10.1001/jama.2022.0003 Yamamoto, 2021, Pathological mechanisms of bortezomib-induced peripheral neuropathy, Int. J. Mol. Sci., 22, 888, 10.3390/ijms22020888 Velasco, 2019, Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: from pathogenesis to treatment, J. Peripher. Nerv. Syst., 24, S52 Li, 2020, Characteristics and risk factors of bortezomib induced peripheral neuropathy: a systematic review of phase III trials, Hematol. Oncol., 38, 229, 10.1002/hon.2706 May, 2019, Three neglected numbers in the CBC: the RDW, MPV, and NRBC count, Cleve. Clin. J. Med., 86, 167, 10.3949/ccjm.86a.18072 Koma, 2013, Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer, PLoS One, 8, 10.1371/journal.pone.0080240 Albayrak, 2014, Red cell distribution width as a predictor of prostate cancer progression, Asian Pac. J. Cancer Prev. APJCP, 15, 7781, 10.7314/APJCP.2014.15.18.7781 Chen, 2015, A nomogram to predict prognostic value of red cell distribution width in patients with esophageal cancer, Mediat. Inflamm., 2015, 10.1155/2015/854670 Li, 2017, Red blood cell distribution width: a novel predictive indicator for cardiovascular and cerebrovascular diseases, Dis. Markers, 2017, 10.1155/2017/7089493 Poz, 2019, Diagnostic and prognostic relevance of red blood cell distribution width for vascular aging and cardiovascular diseases, Rejuvenation Res., 22, 146, 10.1089/rej.2018.2094 Zinellu, 2022, Platelet and red blood cell volume indices in patients with rheumatoid arthritis: a systematic review and meta-analysis, Diagnostics, 12, 2633, 10.3390/diagnostics12112633 Gao, 2018, Red blood cell distribution width and neutrophil to lymphocyte ratio are correlated with disease activity of dermatomyositis and polymyositis, J. Clin. Lab. Anal., 32, 10.1002/jcla.22209 Taha, 2022, Can complete blood count picture tell us more about the activity of rheumatological diseases, Clin. Med. Insights Arthritis Musculoskelet. Disord., 15, 10.1177/11795441221089182 Chen, 2022, Is RDW a clinically relevant prognostic factor for newly diagnosed multiple myeloma? A systematic review and meta-analysis, BMC Cancer, 22, 796, 10.1186/s12885-022-09902-9 Richardson, 2008, Bortezomib in the front-line treatment of multiple myeloma, Expert Rev. Anticancer Ther., 8, 1053, 10.1586/14737140.8.7.1053 Zhao, 2014, Elevated red cell distribution width level is associated with oxidative stress and inflammation in a canine model of rapid atrial pacing, Int. J. Cardiol., 174, 174, 10.1016/j.ijcard.2014.03.189 Xiong, 2017, Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients, Sci. Rep., 7, 2709, 10.1038/s41598-017-02904-9 2020, [The guidelines for the diagnosis and management of multiple myeloma in China(2020 revision)], Zhonghua Nei Ke Za Zhi, 59, 341 2022, [Guidelines for the diagnosis and management of multiple myeloma in China (2022 revision)], Zhonghua Nei Ke Za Zhi, 61, 480 2017, [The guidelines for the diagnosis and management of multiple myeloma in China (2017 revision)], Zhonghua Nei Ke Za Zhi, 56, 866 Burgess, 2021, Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment, Oncol Ther, 9, 385, 10.1007/s40487-021-00168-y Kumar, 2017, Impact of concomitant dexamethasone dosing schedule on bortezomib-induced peripheral neuropathy in multiple myeloma, Br. J. Haematol., 178, 756, 10.1111/bjh.14754 Salvagno, 2015, Red blood cell distribution width: a simple parameter with multiple clinical applications, Crit. Rev. Clin. Lab Sci., 52, 86, 10.3109/10408363.2014.992064 Zheng, 2012, Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy, Exp. Neurol., 238, 225, 10.1016/j.expneurol.2012.08.023 Cavaletti, 2007, Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat, Exp. Neurol., 204, 317, 10.1016/j.expneurol.2006.11.010 Maharjan, 2014, Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition, Sci. Rep., 4, 5896, 10.1038/srep05896 Yan, 2021, The molecular and cellular insight into the toxicology of bortezomib-induced peripheral neuropathy, Biomed. Pharmacother., 142, 10.1016/j.biopha.2021.112068 Duggett, 2017, Characterization of a rat model of bortezomib-induced painful neuropathy, Br. J. Pharmacol., 174, 4812, 10.1111/bph.14063 Goyal, 2017, Prognostic significance of red blood cell distribution width in gastrointestinal disorders, World J. Gastroenterol., 23, 4879, 10.3748/wjg.v23.i27.4879 Goel, 2022, Mechanistic involvement of inflammation in bortezomib-induced peripheral neuropathy, Comb. Chem. High Throughput Screen., 25, 1595, 10.2174/1386207325666220524144147 Alé, 2014, Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model, Exp. Neurol., 253, 165, 10.1016/j.expneurol.2013.12.020 Moschetti, 2019, Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy, J. Neuroinflammation, 16, 89, 10.1186/s12974-019-1461-0 Liu, 2016, Upregulation of CCL2 via ATF3/c-Jun interaction mediated the Bortezomib-induced peripheral neuropathy, Brain Behav. Immun., 53, 96, 10.1016/j.bbi.2015.11.004 Zhang, 2014, TNF-α-mediated JNK activation in the dorsal root ganglion neurons contributes to Bortezomib-induced peripheral neuropathy, Brain Behav. Immun., 38, 185, 10.1016/j.bbi.2014.01.020